Morningstar

Morningstar, Inc.

Equity Bottom-Up

Quest Diagnostics has positioned itself as the leading provider of independent diagnostic testing in the U.S. by building out a network of more than 2,000 patient service centers across the country. We think Quest's size and cost advantage will allow it to benefit from several secular trends, including the proliferation diagnostic tests and greater clinical reliance on personalized therapies. Additionally, we expect that over the longer term, reimbursement pressure will push hospital-based labs…

United States

Quest Diagnostics Incorporated provides diagnostic testing, information, and services.  The Company operates a national network of full-service laboratories, rapid response laboratories, and patient service centers.  Quest Diagnostics provides esoteric testing, routine medical testing, drugs of abuse testing, and non-hospital-based anatomicpathology testing.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00